Bioshield Anthrax Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioshield Anthrax Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioshield Anthrax Program Today - Breaking & Trending Today

Paratek Pharmaceuticals Announces Full-Year 2022 Revenue of $160.3 Million

Published: March 16, 2023

16.03.2023 - - NUZYRA (omadacycline) Generated Net U.S. Sales of $98.7 Million from the Core Commercial Business, a 45% Increase Over the Prior Year - Continued Progress on the Rare Disease Nontuberculous Mycobacteria (NTM) & BARDA Project BioShield Anthrax ...

Source: wallstreet-online.de

Related Topics:

United StatesChristine FanelleEvan LohHans VitzthumUs Department Of HealthZai LabParatek Pharmaceuticals IncDevelopment AuthorityBioshield Anthrax ProgramExchange CommissionHuman Service Biomedical Advanced ResearchDevelopment ProgramDevice AgencyRare Disease ProgramProject BioshieldTuberculous MycobacteriaMedical Device AgencyInvestor RelationsParatek PharmaceuticalsAnnual ReportConsolidated Statement